1 specimens by quantitative real-time PCR and
immunohistochemical analyses.
2 utant P301S tau mouse, using biochemical and
immunohistochemical analyses.
3 , 12, and 24 hours, and 2, 4, and 7 days for
immunohistochemical analyses.
4 nerves were embedded in paraffin and cut for
immunohistochemical analyses.
5 luorescence microscopy, and histological and
immunohistochemical analyses.
6 ns in Trained versus Untrained rats based on
immunohistochemical analyses.
7 were determined using flow cytometry and/or
immunohistochemical analyses.
8 r injury and brain sections were stained for
immunohistochemical analyses.
9 3 activation were examined by immunoblot and
immunohistochemical analyses.
10 at was further confirmed by Western blot and
immunohistochemical analyses.
11 proteins were subjected to Western blot and
immunohistochemical analyses.
12 was investigated with both western blot and
immunohistochemical analyses.
13 week for 4 months and subsequently conducted
immunohistochemical analyses.
14 varying grades of degeneration were used for
immunohistochemical analyses.
15 r subtypes was evaluated by Western blot and
immunohistochemical analyses.
16 sue was processed for DiI-labeling fiber and
immunohistochemical analyses.
17 inal tissues were collected from embryos for
immunohistochemical analyses.
18 in the TMJ, assessed by histopathologic and
immunohistochemical analyses.
19 s were confirmed with ex vivo histologic and
immunohistochemical analyses.
20 th reduced Fhit expression, as determined by
immunohistochemical analyses.
21 tligation and processed for morphometric and
immunohistochemical analyses.
22 c reticulum by subcellular fractionation and
immunohistochemical analyses.
23 tex was examined with immunofluorescence and
immunohistochemical analyses.
24 med gene expression, immunofluorescence, and
immunohistochemical analyses.
25 ma samples was confirmed by Western blot and
immunohistochemical analyses.
26 ranscriptase-PCR, in situ hybridization, and
immunohistochemical analyses.
27 were collected and analyzed by histology and
immunohistochemical analyses.
28 ngle nucleotide polymorphisms, and performed
immunohistochemical analyses.
29 um was examined by in situ hybridization and
immunohistochemical analyses.
30 sessments via ex vivo pressure myography, or
immunohistochemical analyses.
31 ed for transmission electron microscopic and
immunohistochemical analyses.
32 PCR, enzyme-linked immunosorbent assay, and
immunohistochemical analyses.
33 ralateral hemisphere via ultrastructural and
immunohistochemical analyses.
34 analyzed by histologic, flow cytometry, and
immunohistochemical analyses.
35 on of HDAC2 in mice retinas was evaluated by
immunohistochemical analyses.
36 y in situ hybridization, flow cytometry, and
immunohistochemical analyses.
37 n region was evaluated using histometric and
immunohistochemical analyses.
38 epatocellular tumors can be classified using
immunohistochemical analyses.
39 ion proteins, and performed H&E staining and
immunohistochemical analyses.
40 obtain reference values for histological and
immunohistochemical analyses.
41 re collected and evaluated by histologic and
immunohistochemical analyses.
42 For the
immunohistochemical analyses,
26 studies were included t
43 ne and chemokine levels, and microscopic and
immunohistochemical analyses 7 through 42 days after T c
44 The histological and
immunohistochemical analyses also demonstrate the inhibi
45 Immunohistochemical analyses and a cell-depletion approa
46 nal antibody (24F3.F11) for Western blot and
immunohistochemical analyses and an antisense riboprobe
47 Immunohistochemical analyses and live cortical imaging o
48 l morphology were assessed by histologic and
immunohistochemical analyses and those on retinal functi
49 Biochemical assays, histological and
immunohistochemical analyses,
and biomechanical testing
50 examination, light and electron microscopy,
immunohistochemical analyses,
and real-time quantitative
51 cterized in flow cytometric, histologic, and
immunohistochemical analyses as well as RNA analyses.
52 ein was isolated, and samples were fixed for
immunohistochemical analyses at 0, 6, and 72 hours after
53 alyses, gene sequencing, immunoblotting, and
immunohistochemical analyses at 10 days and 6 months pos
54 Histochemical and
immunohistochemical analyses at 5 and 10 weeks after inf
55 g of the thoracic aorta for morphometric and
immunohistochemical analyses at 7 or 21 days.
56 te element modeling, mechanical testing, and
immunohistochemical analyses at multiple time points thr
57 Western blot and
immunohistochemical analyses both revealed a substantial
58 Morphometric and
immunohistochemical analyses confirm progressive change.
59 Northern, Western blot, and
immunohistochemical analyses confirm that expression of
60 Western and
immunohistochemical analyses confirmed elevated PAD2 and
61 Immunohistochemical analyses confirmed localization of a
62 Immunohistochemical analyses confirmed selective ChR2 ex
63 Immunohistochemical analyses confirmed sustained increas
64 Western blot and
immunohistochemical analyses confirmed that all five mAC
65 Biochemical and
immunohistochemical analyses confirmed that at least som
66 Western immunoblot and
immunohistochemical analyses confirmed that the cellular
67 Immunohistochemical analyses confirmed that the level of
68 Biochemical and
immunohistochemical analyses confirmed the TSPO small-an
69 Virological, histopathological, and
immunohistochemical analyses confirmed uncontrolled BDBV
70 Western blot and
immunohistochemical analyses corroborated the mRNA studi
71 Accordingly, RNA-seq and
immunohistochemical analyses demonstrate an ER-dependent
72 Immunohistochemical analyses demonstrated a corresponden
73 Immunohistochemical analyses demonstrated down-regulatio
74 Immunohistochemical analyses demonstrated gammaHV68 anti
75 Immunohistochemical analyses demonstrated jagged-1 expre
76 In situ hybridization and
immunohistochemical analyses demonstrated minimal expres
77 Immunohistochemical analyses demonstrated that apoB-48 p
78 Immunohistochemical analyses demonstrated that corpora l
79 Immunohistochemical analyses demonstrated that CYP4V2 pr
80 Immunohistochemical analyses demonstrated that inactivat
81 In fact, double label
immunohistochemical analyses demonstrated that over 90%
82 Immunohistochemical analyses demonstrated that the SC pr
83 Immunohistochemical analyses demonstrated that, as follo
84 in10 as biphasic tumor-related claudins, and
immunohistochemical analyses demonstrated the localizati
85 ion, fluorescence in situ hybridization, and
immunohistochemical analyses determined that DCD is over
86 smission electron microscopic and multilabel
immunohistochemical analyses disclosed bacteria with sev
87 In cases of human lung and colon cancers,
immunohistochemical analyses evidenced frequent attenuat
88 Immunohistochemical analyses ex vivo included stainings
89 Immunohistochemical analyses for detecting the receptor
90 We performed
immunohistochemical analyses for expression of Notch and
91 We performed
immunohistochemical analyses for infiltrating immune cel
92 imal models was examined using histology and
immunohistochemical analyses for osteopontin, runt-relat
93 obtained and used for histomorphometric and
immunohistochemical analyses for the detection of osteoc
94 Here, we analyzed 130 breast carcinomas via
immunohistochemical analyses for the levels of nuclear a
95 was applied in combination with chemical and
immunohistochemical analyses for these characterizations
96 Behavioral and
immunohistochemical analyses further indicated that post
97 Gene expression profiling studies and
immunohistochemical analyses have highlighted the import
98 Immunofluorescence and
immunohistochemical analyses imaged morphologic changes
99 Immunohistochemical analyses in diverse insect species r
100 overexpression of MUC17 by Western blot and
immunohistochemical analyses in pancreatic tumor cell li
101 Data from
immunohistochemical analyses in serial sections of norma
102 h numbers of Foxp3(+) Treg cells, evident by
immunohistochemical analyses in situ, the CTLA-4 antibod
103 We performed behavioral, molecular, and
immunohistochemical analyses in two transgenic models of
104 atory molecules, determined by pathology and
immunohistochemical analyses,
in a training set of 228 H
105 n female-predominant polycystic livers using
immunohistochemical analyses,
including multiplex quantu
106 Immunohistochemical analyses indicate that Apc expressio
107 Western blot and
immunohistochemical analyses indicate that brain injury
108 Transcriptomic and
immunohistochemical analyses indicated that increased HG
109 Immunohistochemical analyses indicated that phosphorylat
110 Flow-cytometric and
immunohistochemical analyses indicated that RGS10-defici
111 Based on
immunohistochemical analyses,
levels of Thy1 were signif
112 Immunohistochemical analyses localized the elevated NT-3
113 Immunohistochemical analyses may assist in the diagnosis
114 d, when combined with careful histologic and
immunohistochemical analyses,
may serve as a research to
115 Northern, Western, and
immunohistochemical analyses measured PAD2 expression an
116 By
immunohistochemical analyses of 148 tissues from 89 pros
117 Immunohistochemical analyses of 9 biopsied pigmented les
118 We performed
immunohistochemical analyses of a 445 PDAC specimens, co
119 Furthermore,
immunohistochemical analyses of a subset of these transc
120 Immunoblotting and
immunohistochemical analyses of A549 xenograft tissues w
121 Immunohistochemical analyses of atherosclerotic plaques
122 Immunohistochemical analyses of Bcl-2 and FLIP revealed
123 ns were extended to include a spatiotemporal
immunohistochemical analyses of beta-catenin and alpha-c
124 We sought to determine whether
immunohistochemical analyses of biopsies from patients w
125 Moreover,
immunohistochemical analyses of biopsy samples from pati
126 Immunohistochemical analyses of bovine cornea yielded si
127 Western blot and
immunohistochemical analyses of cells cultured in hypert
128 Finally,
immunohistochemical analyses of cervical carcinoma in si
129 Immunohistochemical analyses of CRC tissues further corr
130 Immunohistochemical analyses of cross sections of aorta
131 Immunohistochemical analyses of cultured Aplysia neurons
132 We performed
immunohistochemical analyses of distal ileum tissues fro
133 Immunohistochemical analyses of E2F3 protein levels have
134 Our multilineage
immunohistochemical analyses of early embryonic rat tele
135 allel fluorescence in situ hybridization and
immunohistochemical analyses of EEF1A2 and KCIP-1 in tis
136 Immunohistochemical analyses of endobronchial biopsies s
137 Immunohistochemical analyses of expressed adenoviral pro
138 Microarray and
immunohistochemical analyses of genes expressed by the m
139 Immunohistochemical analyses of granzyme B, perforin, Fa
140 Immunohistochemical analyses of hagfish tissues and bloo
141 Western blot and
immunohistochemical analyses of heart tissue samples fur
142 Immunoblotting and
immunohistochemical analyses of HIV-1 seropositive and H
143 Immunohistochemical analyses of HIV-1 Tat transgenic mou
144 Immunohistochemical analyses of human and mouse lumbar s
145 Immunohistochemical analyses of human and rat trigeminal
146 Transcriptomic and
immunohistochemical analyses of human breast tumors reve
147 Immunohistochemical analyses of human carcinomas have co
148 Immunohistochemical analyses of human CCA tissues showed
149 Immunohistochemical analyses of human eyes with glaucoma
150 Third,
immunohistochemical analyses of human HIVE tissue define
151 ed media of human cartilage explants, and by
immunohistochemical analyses of human OA cartilage.
152 Immunohistochemical analyses of human ovarian cancer spe
153 with that of an anti-E-selectin antibody, by
immunohistochemical analyses of human synovial sections
154 We performed
immunohistochemical analyses of human tissue microarrays
155 We performed
immunohistochemical analyses of inflamed and noninflamed
156 repertoire is derived from histological and
immunohistochemical analyses of insulitis, the identific
157 Immunohistochemical analyses of intestinal tissues were
158 Immunohistochemical analyses of kidney biopsies from liv
159 Immunoblot and
immunohistochemical analyses of lysates of carotid arter
160 nsecutive patients, performing MSI tests and
immunohistochemical analyses of MMR proteins.
161 Gene expression and
immunohistochemical analyses of murine tumors identified
162 Immunohistochemical analyses of nasopharyngeal carcinoma
163 Our results of electromicroscopic and
immunohistochemical analyses of neuronal and synaptic ul
164 Immunohistochemical analyses of olfactory marker protein
165 Immunohistochemical analyses of p53, epidermal growth fa
166 Finally,
immunohistochemical analyses of patient specimens confir
167 Clinically, in silico gene expression and
immunohistochemical analyses of patient specimens showed
168 Immunohistochemical analyses of pediatric brain tissue s
169 ed vascular network with pharmacological and
immunohistochemical analyses of pericytes, the capillary
170 Immunohistochemical analyses of posttherapy tumor specim
171 We performed
immunohistochemical analyses of primary ESCC samples and
172 Real-time PCR and
immunohistochemical analyses of primary human and mouse
173 Semiquantitative
immunohistochemical analyses of PY-Shc and p66 Shc were
174 Western blot and
immunohistochemical analyses of rat brain further indica
175 By
immunohistochemical analyses of rat brain, PP1beta and P
176 Further, echocardiographic and
immunohistochemical analyses of recipient hearts showed
177 quence, whole-exome and genome sequence, and
immunohistochemical analyses of select samples.
178 Light and electron microscopic
immunohistochemical analyses of several pedigrees of pos
179 ay, real-time polymerase chain reaction, and
immunohistochemical analyses of skin of downless mice re
180 We therefore carried out immunoblot and
immunohistochemical analyses of the different AUBPs usin
181 Immunohistochemical analyses of the distribution of mGlu
182 Immunohistochemical analyses of the lung tissue substant
183 Immunohistochemical analyses of the oral lesions reveale
184 RP-li) in the enteric plexuses, we performed
immunohistochemical analyses of the small intestinal sub
185 Immunohistochemical analyses of the tumors revealed a de
186 Immunohistochemical analyses of the wounds 5 and 10 days
187 Immunohistochemical analyses of these tissue specimens f
188 Immunohistochemical analyses of tissue arrays containing
189 Immunohistochemical analyses of tissue obtained at diagn
190 f antigen expression in the disease setting,
immunohistochemical analyses of tissues from patients wi
191 Electroretinographic and
immunohistochemical analyses of treated retinas were car
192 Immunohistochemical analyses of tumor tissues obtained f
193 Immunohistochemical analyses of tumors formed in nude mi
194 Immunohistochemical analyses of two independent clinical
195 Immunohistochemical analyses of vagal motoneurones showe
196 Immunohistochemical analyses of WT1 and CD138 in bone ma
197 Immunohistochemical analyses of xxt5 plants revealed a s
198 ver group-specific molecular markers and did
immunohistochemical analyses on 125 primary tumours to e
199 orrelated and validated by real-time PCR and
immunohistochemical analyses on a series of 100 cases of
200 Immunohistochemical analyses on bladder cancer tissue ar
201 s, we conducted detailed histopathologic and
immunohistochemical analyses on paraffin-embedded pancre
202 Immunohistochemical analyses on tissue arrays sustained
203 We performed
immunohistochemical analyses on tissue microarrays of 10
204 The results of our
immunohistochemical analyses on tumor specimens from 63
205 In
immunohistochemical analyses or using expression of fluo
206 r (BC); however, the limitations inherent to
immunohistochemical analyses prevent comprehensive descr
207 atal rat cerebellum by using biochemical and
immunohistochemical analyses,
respectively.
208 ctory responses to a number of odorants, and
immunohistochemical analyses reveal a near-complete loss
209 Immunohistochemical analyses reveal that endogenous GLP-
210 Transcriptome and
immunohistochemical analyses reveal that PI3K pathway ac
211 Immunohistochemical analyses reveal that proprioceptive
212 Immunohistochemical analyses reveal that the responding
213 Pharmacological and
immunohistochemical analyses reveal that these neurons l
214 Immunohistochemical analyses revealed a "shift" in HSP27
215 Bioinformatic and
immunohistochemical analyses revealed a correlation betw
216 novium decreased after treatment with L-NIL,
immunohistochemical analyses revealed a distinct pattern
217 Microscopic and
immunohistochemical analyses revealed a time course for
218 Immunohistochemical analyses revealed abundant immunosta
219 Lineage tracing and
immunohistochemical analyses revealed clonal expansion o
220 Immunohistochemical analyses revealed colocalization of
221 Immunohistochemical analyses revealed extravasated plasm
222 Immunohistochemical analyses revealed robust expression
223 Finally,
immunohistochemical analyses revealed that Bim expressio
224 Immunohistochemical analyses revealed that cells in the
225 Immunohistochemical analyses revealed that EPCR expressi
226 Immunohistochemical analyses revealed that immunoreactiv
227 The data from immunoblot and/or
immunohistochemical analyses revealed that multiple expo
228 Western blot and
immunohistochemical analyses revealed that NLS-N171-82Q
229 Together, ultrastructural and
immunohistochemical analyses revealed that the fusion of
230 Immunohistochemical analyses revealed that the human vit
231 Immunohistochemical analyses revealed that the mPOA modu
232 Biochemical and
immunohistochemical analyses revealed that these protein
233 In situ hybridization and
immunohistochemical analyses revealed that tissue macrop
234 Immunohistochemical analyses revealed the active form of
235 t 4 or 8 weeks and used for histological and
immunohistochemical analyses,
RNase protection assay, an
236 Immunohistochemical analyses show that the AM peptide is
237 Finally,
immunohistochemical analyses showed 8S-LOX protein expre
238 In situ hybridization and
immunohistochemical analyses showed increased OPN mRNA a
239 Immunohistochemical analyses showed increased phospho-mT
240 Immunohistochemical analyses showed intense mGluR1 alpha
241 Immunohistochemical analyses showed no changes in muscle
242 Immunohistochemical analyses showed that brain-dead pati
243 Immunohistochemical analyses showed that cells produced
244 Immunohistochemical analyses showed that D2R and D3R GFP
245 Immunohistochemical analyses showed that IL-1alpha was e
246 Our in silico and
immunohistochemical analyses showed that KIAA1199 is spe
247 In addition,
immunohistochemical analyses showed that multiple sclero
248 Immunohistochemical analyses showed that PCPH is not exp
249 Immunohistochemical analyses showed that SKNAS iCSC xeno
250 Molecular and
immunohistochemical analyses showed that the OTK18 nucle
251 transcriptase-polymerase chain reaction and
immunohistochemical analyses showed that the SPN mRNA an
252 Immunohistochemical analyses showed that these structure
253 Hematoxylin and eosin and
immunohistochemical analyses showed the numbers of neutr
254 Immunohistochemical analyses similarly revealed signific
255 Immunohistochemical analyses suggest alterations either
256 EM
immunohistochemical analyses suggest that intermediate c
257 Immunohistochemical analyses suggest that SpCOUP-TF is a
258 Immunohistochemical analyses suggested that both BSX1A a
259 Although in situ hybridization and
immunohistochemical analyses suggested that Fkbp52 mutan
260 Gene expression and
immunohistochemical analyses suggested that the cancer-a
261 Immunohistochemical analyses support a model in which th
262 mographic, histopathologic, histometric, and
immunohistochemical analyses the effects of local admini
263 In
immunohistochemical analyses,
the autophagosome protein
264 ies and EMSP1 expression by Western blot and
immunohistochemical analyses,
the cloning and characteri
265 We performed metabolic studies and
immunohistochemical analyses to determine the effects of
266 Here, we used immunoblot and
immunohistochemical analyses to determine whether the pr
267 -2/neu-positive breast cancers, we performed
immunohistochemical analyses to evaluate expression of H
268 We used
immunohistochemical analyses to examine the expression o
269 ide microarray profiling and biochemical and
immunohistochemical analyses to identify molecular deter
270 We used
immunohistochemical analyses to study retinal glia, neur
271 Similar
immunohistochemical analyses using NF-M-deficient mice s
272 Immunohistochemical analyses using this anti-rKv3.1 anti
273 In this study, we have performed
immunohistochemical analyses,
using affinity-purified an
274 Immunohistochemical analyses verified intense and restri
275 ase chain reaction, immunoprecipitation, and
immunohistochemical analyses,
we assessed expression of
276 Using immunoblot and
immunohistochemical analyses,
we find that in chronic sa
277 In
immunohistochemical analyses,
we found that the invasive
278 Using
immunohistochemical analyses,
we measured the expression
279 nd confirmatory real-time PCR, ELISA, and/or
immunohistochemical analyses were carried out on a numbe
280 e a possible connection between AKT and FAS,
immunohistochemical analyses were conducted on an ovaria
281 Immunohistochemical analyses were employed for screening
282 Intestinal tissues were collected;
immunohistochemical analyses were performed for MSH2, al
283 f the procedure, animals were sacrificed and
immunohistochemical analyses were performed for three IT
284 the cellular distribution of the human RFC,
immunohistochemical analyses were performed in CCRF-CEM
285 Histologic and
immunohistochemical analyses were performed on a corneal
286 Clinical, histopathologic, and
immunohistochemical analyses were performed on all ident
287 Immunohistochemical analyses were performed on human (n
288 In parallel,
immunohistochemical analyses were performed on human mus
289 Morphometric and
immunohistochemical analyses were performed on the aorti
290 Histologic and
immunohistochemical analyses were performed to character
291 Immunohistochemical analyses were performed using a new
292 autoantibody detection, and detailed tissue
immunohistochemical analyses were performed.
293 Histopathological and
immunohistochemical analyses were performed.
294 Histologic, histometric, and
immunohistochemical analyses were performed.
295 Western blotting, oligo-microarray, and
immunohistochemical analyses were used to determine the
296 Western blot and
immunohistochemical analyses were used to evaluate TSA-i
297 Immunohistochemical analyses were used to quantify myosi
298 Immunohistochemical analyses with Ki67 staining confirme
299 Immunohistochemical analyses with peanut agglutinin and
300 Immunohistochemical analyses with TSPO antisera, methoxy